The Use of Exhaled Nitric Oxide in Conjunction With the Asthma Control Test to Determine Asthma Control in Pediatric Patients

Akron Children's Hospital

Status: Terminated

Conditions: Asthma

Study type: Observational

Funder types: Other

Identifiers

NCT00575445

eNO/ACT Study

Details and patient eligibility

About

The purpose of this study is to determine if exhaled nitric oxide (eNO) levels will be increased in pediatric patients with uncontrolled asthma as determined by the Asthma Control Test (ACT). During the study the investigators will also examine if the combination of eNO and ACT will better predict asthma control that either tool alone when compared to a medical provider's assessment of the patient's asthma control.

Enrollment: 100 estimated patients

Sex: All

Ages: 6 to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of asthma by pediatric pulmonologist
• Age 6-18 years

Exclusion criteria

• Age <6 years or >18 years
• history of bronchopulmonary dysplasia
• history of cystic fibrosis
• history of primary ciliary dyskinesia
• current acute asthma exacerbation
• current acute viral upper respiratory infection
• recent ingestion of nitrate-rich foods

Trial design

100 participants in 1 patient group

1

Description:

Pediatric patients with previously diagnosed asthma